Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Immune Deficiency Disorder”

116 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 116 results

Not applicableStudy completedNCT03369301
What this trial is testing

The Effect of Subcutaneous Immunoglobulin Gammanorm on the Distribution of IgG Subclasses and on Immunity of Patients With Secondary Immunodeficiency

Who this might be right for
Secondary Immune Deficiency
Octapharma 102
Early research (Phase 1)Study completedNCT03329950
What this trial is testing

CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies

Who this might be right for
MelanomaNon-small Cell Lung CancerBreast Cancer+23 more
Celldex Therapeutics 132
Early research (Phase 1)Ended earlyNCT01249443
What this trial is testing

Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection

Who this might be right for
HIV InfectionRecurrent Anal CancerRecurrent Breast Cancer+31 more
AIDS Malignancy Consortium 17
Not applicableStudy completedNCT00050089
What this trial is testing

CSP #512 - Options in Management With Anti-Retrovirals

Who this might be right for
AIDSHIV Infections
US Department of Veterans Affairs 368
Large-scale testing (Phase 3)Study completedNCT00038519
What this trial is testing

Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following Failure With Kaletra as Their Second Protease Inhibitor

Who this might be right for
HIV Infections
Abbott 16
Not applicableActive Not RecruitingNCT05321407
What this trial is testing

COVID-19 Vaccine Responses in PIDD Subjects

Who this might be right for
X-linked AgammaglobulinemiaXLAPrimary Immune Deficiency+4 more
Duke University 100
Not applicableStudy completedNCT01414660
What this trial is testing

Evolution of Interleukin 7, Fat Mass and Metabolic Profile Before and After Transplantation

Who this might be right for
Immunodeficiency Secondary to Organ Transplantation
University Hospital, Lille 49
Large-scale testing (Phase 3)Study completedNCT01511237
What this trial is testing

Perinatal Antiretroviral Intensification for PMTCT of HIV in Late Comers

Who this might be right for
HIV Infections
Institut de Recherche pour le Developpement 379
Not applicableStudy completedNCT03250845
What this trial is testing

Comparison of Multigam IV (5% vs. 10%) in Patients With an Immunodeficiency Secondary to a Hematological Disorder

Who this might be right for
Hematologic DiseasesSecondary Immune Deficiency
Universitaire Ziekenhuizen KU Leuven 30
Not applicableStudy completedNCT06285110
What this trial is testing

HIV-1 Subtype-specific Drug Resistance in Patients Failing Dolutegravir (DTG) Based Regimen

Who this might be right for
Hiv
University of Bern 1,103
Early research (Phase 1)Ended earlyNCT04458259
What this trial is testing

Study of PF-07265807 in Participants With Metastatic Solid Tumors.

Who this might be right for
Neoplasm Metastasis
Pfizer 88
Large-scale testing (Phase 3)UnknownNCT01108614
What this trial is testing

Injecting Drug Use Community Intervention Trial

Who this might be right for
HIVHepatitis CSyphilis+2 more
National Center for AIDS/STD Control and Prevention, China CDC 12,000
Not applicableStudy completedNCT00476606
What this trial is testing

A Prospective Cohort of Children With HIV Infection

Who this might be right for
HIV Infections
The HIV Netherlands Australia Thailand Research Collaboration 500
Testing effectiveness (Phase 2)Ended earlyNCT00432419
What this trial is testing

Therapeutic Intensification of HIV-associated Non-Hodgkin's Lymphoma by Peripheral Blood Cell Transplantation Following Chemotherapy.

Who this might be right for
HIV InfectionsLymphoma, Non-Hodgkin
French National Agency for Research on AIDS and Viral Hepatitis 1
Not applicableLooking for participantsNCT06821880
What this trial is testing

Developing a Patient-Reported Outcome (PRO) Screening Measure for Infections and Measuring Quality of Life in Hematological Patients With Secondary Immunodeficiency (SID) Across the Treatment Trajectory - The PRO SID Project

Who this might be right for
Chronic Lymphocytic Leukaemia (CLL)Multiple Myeloma (MM)Secondary Immunodeficiency (SID)
Medical University Innsbruck 120
Not applicableLooking for participantsNCT06989541
What this trial is testing

Immunoglobulin for Hypogammaglobulinemia Due to Chimeric Antigen Receptor T Cell Therapy

Who this might be right for
Hypogammaglobulinemia, Acquired
University of Alberta 30
Testing effectiveness (Phase 2)Study completedNCT01368107
What this trial is testing

Study Evaluating Impact of IL-7 on CD4 Lymphopenia, Risks of Severe Haematological Toxicity and Tumor Progression in Metastatic Breast Cancer Patients

Who this might be right for
Metastatic Breast Cancer
Centre Leon Berard 24
Not applicableStudy completedNCT00000744
What this trial is testing

A Randomized, Prospective, Double-Blind Study Comparing Fluconazole With Placebo for Primary and Secondary Prophylaxis of Mucosal Candidiasis in HIV-Infected Women

Who this might be right for
CandidiasisCandidiasis, EsophagealHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 400
Not applicableStudy completedNCT05074251
What this trial is testing

Evaluation of Secondary Distribution of HIV Self-screening Tests by Women With HIV

Who this might be right for
HIV InfectionsARTHIV Seropositivity
University of California, Los Angeles 180
Testing effectiveness (Phase 2)Active Not RecruitingNCT05200559
What this trial is testing

T-regulatory Cell Depletion With E7777 Combined With Pembrolizumab in Recurrent or Metastatic Solid Tumors

Who this might be right for
Epithelial Ovarian Cancer
Alexander B Olawaiye, MD 25
Next Page